Jean-Marc Fritschy

Jean-Marc Fritschy

Auto-generated profile, based on publicly available information

Jean-Marc Fritschy

University of Zurich, Institute of Pharmacology and Toxicology, 8057, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 1995 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
JFJean‐Marc Fritschy
Jean‐Marc Fritschy
HMHanns Mohler
Hanns Mohler

1 October 1999 in Nature
Verified
Journal Article
Closed access
URUwe Rudolph
Uwe Rudolph
FCFlorence Crestani
Florence Crestani
DBDietmar Benke
Dietmar Benke
IBIna Brünig
Ina Brünig
JBJack A. Benson
Jack A. Benson
HMHanns Möhler
Hanns Möhler

6 October 2000 in Science
Verified
Journal Article
Closed access
PDF file
KLKarin Löw
Karin Löw
FCFlorence Crestani
Florence Crestani
RKRuth Keist
Ruth Keist
DBDietmar Benke
Dietmar Benke
IBIna Brünig
Ina Brünig
URUwe Rudolph
Uwe Rudolph
Benzodiazepine tranquilizers are used in the treatment of anxiety disorders. To identify the molecular and neuronal target mediating the anxiolytic action of benzodiazepines, we generated and analyzed two mouse lines in which the α2 or α3 GABA A (γ-aminobutyric acid type A) receptors, respectively, were rendered insensitive to diazepam by a knock-in point mutation. The anxiolytic action of diazepam was absent in mice with the α2(H101R) point mutation but present in mice with the α3(H126R) point mutation. These findings indicate that the anxiolytic effect of benzodiazepine drugs is mediated by α2 GABA A receptors, which are largely expressed in the limbic system, but not by α3 GABA A receptors, which predominate in the reticular activating system.

1 November 1998 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
CEChristian Essrich
Christian Essrich
MLMatthias Lorez
Matthias Lorez
JBJack A. Benson
Jack A. Benson
JFJean-Marc Fritschy
Jean-Marc Fritschy
BLBernhard Lüscher
Bernhard Lüscher

1 January 2002 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
PDF file
HMH. Möhler
H. Möhler
JFJ. M. Fritschy
J. M. Fritschy
URU. Rudolph
U. Rudolph
Classical benzodiazepine drugs are in wide clinical use as anxiolytics, hypnotics, anticonvulsants, and muscle relaxants. They act by enhancing the γ-aminobutyric acidA (GABAA) receptor function in the central nervous system. The pharmacological relevance of the multitude of structurally diverse GABAAreceptor subtypes has only recently been identified. Based on an in vivo point mutation strategy, α1-GABAAreceptors were found to mediate sedation, anterograde amnesia, and part of the seizure protection, whereas α2-GABAAreceptors, but not α3-receptors, mediate anxiolysis. Rational drug targeting to specific receptor subtypes has now become possible. Only restricted neuronal networks will be modulated by the new subtype-selective drugs. Promising new anxiolytics have already been developed. A new pharmacology of the benzodiazepine site is on the horizon.

25 June 2002 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
FCF. Crestani
F. Crestani
RKR. Keist
R. Keist
JFJ.-M. Fritschy
J.-M. Fritschy
DBD. Benke
D. Benke
KVK. Vogt
K. Vogt
URU. Rudolph
U. Rudolph
The heterogeneity of γ-aminobutyric acid type A (GABA A ) receptors contributes to the diversity of neuronal inhibition in the regulation of information processing. Although most GABA A receptors are located synaptically, the small population of α 5 GABA A receptors is largely expressed extrasynaptically. To clarify the role of the α 5 GABA A receptors in the control of behavior, a histidine-to-arginine point mutation was introduced in position 105 of the murine α 5 subunit gene, which rendered the α 5 GABA A receptors diazepam-insensitive. Apart from an incomplete muscle relaxing effect, neither the sedative, anticonvulsant, nor anxiolytic-like activity of diazepam was impaired in α 5 (H105R) mice. However, in hippocampal pyramidal cells, the point mutation resulted in a selective reduction of α 5 GABA A receptors, which altered the drug-independent behavior. In line with the role of the hippocampus in certain forms of associative learning, trace fear conditioning, but not delay conditioning or contextual conditioning, was facilitated in the mutant mice. Trace fear conditioning differs from delay conditioning in that the conditioned and unconditioned stimulus are separated by a time interval. Thus, the largely extrasynaptic α 5 GABA A receptors in hippocampal pyramidal cells are implicated as control elements of the temporal association of threat cues in trace fear conditioning.